Posted by Michael Wonder on 21 Jul 2025
EMA publishes agenda for 21-24 July 2025 CHMP meeting
21 July 2025 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Lifleucel
- Levacetylleucine
- Denosumab
- Sebetralstat
- Delandistrogene moxeparvovec
- Aflibercept
- Chondrocytes (autologous)
- Lenacapavir
- Macitentan
- Vimseltinib
- Ustekinumab
- Vorasidenib
- Zuranolone
